Here is something I just stumbled upon while searching for news about NorthView:
New Purchase by SkyView Investment Advisors, LLC: NorthView Acquisition Corp (NVACU)
SkyView Investment Advisors, LLC initiated holding in NorthView Acquisition Corp. The purchase prices were between $10.02 and $10.05, with an estimated average price of $10.03. The stock is now traded at around $10.050000. The impact to a portfolio due to this purchase was 0.47%. The holding were 200,000 shares as of 2021-12-31.
About the investment firm:
Established in 2009, our competitive edge is rooted in the deep experience of our world class, research-driven investment management team. SkyView provides comprehensive multi-asset solutions across traditional and alternative strategies designed to help you manage the complexities of your business and accomplish your goals through:
collaborative relationships built on transparency and open architecture solutions, and partnering to support investments, education, and business development.
In total, Skyview Investment Advisors manages $4,108,296,074 in assets.
They bought Units at $10.03 before the end of 2021. I purchased units in January at $10.09.
Old news, but it is nice to see an investment firm purchasing $2 million worth of NVACU at about the time the SPAC had its IPO.
After the units were split, I myself sold off the warrants and shares and focused entirely upon the Rights.
I kind of figured that the Rights carried the most risk (ie: they would have zero value if a merger is not consummated within 24 months), but I also figured that the founders of NorthView get nothing for their efforts until a merger is completed - so they have the motivation to complete a merger, even a bad one, in order to reap the fruits of their efforts.
As NVACR is for 1/10th of a Right to a share, at about .19 per NVACR, it is the equivalent of paying $1.90 for a share of NVAC, which currently is trading at $9.78.
In other words, even if the SPAC's value remained at $9.78 or even dropped, upon consummation, the Rights would still be looking at a 400% to 500% increase in value.
I just felt that since it was my intention to hold until the announcement of the acquisition target (I could still sell NVACR at that time), or even until just after the merger is completed, that NVACR held the highest risk (minimized by the personal agenda's of NorthView's founders) and therefore the highest rewards.
Its a gamble, but one that hopefully will payoff.
Godspeed.
These opinions are my own and are not intended as investment advice. If you feel that my statements are "Pumping", Propaganda, or manipulative in any way, please refrain from trading and seek medical treatment immediately.
